Frontage offers early PK and toxicology studies to identify toxicity and PK issues early on in support of your regulatory studies later.
Contact us to discuss your discovery studies.
Frontage supports early drug discovery with various immunoassays for proteins and therapeutic antibodies to support pharmacokinetics/toxicokinetics (PK/TK), pharmacodynamics (PD), and biomarkers analysis.
Frontage’s discovery team is comprised of experienced medical chemists, biologists,and DMPK scientists that help Sponsors generate hits and leads. We profile, optimize, and advance the compounds to an IND candidate.
In this eBook, we navigate the landscape of biomarker discovery through genomic profiling, exploring technologies, methods, and applications. We hope this collection of articles creates an appreciation for the wide scope of using sequencing assays for biomarker discovery, drug development, and beyond.